US Stock MarketDetailed Quotes

Colgate-Palmolive (CL)

Watchlist
  • 85.550
  • +2.420+2.91%
Close Apr 8 16:00 ET
  • 85.740
  • +0.190+0.22%
Post 19:51 ET
68.64BMarket Cap32.53P/E (TTM)

Colgate-Palmolive (CL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.22%4.2B
14.50%1.45B
8.05%1.26B
-10.71%884M
-11.89%600M
9.67%4.11B
11.71%1.27B
1.30%1.17B
37.12%990M
-7.35%681M
Net income from continuing operations
-25.84%2.26B
-100.64%-5M
-1.03%767M
0.91%773M
-0.41%726M
24.20%3.05B
2.50%779M
3.75%775M
43.45%766M
76.09%729M
Depreciation and amortization
4.13%630M
16.89%173M
5.33%158M
-3.82%151M
-1.33%148M
6.70%605M
-1.33%148M
4.17%150M
8.28%157M
17.19%150M
Deferred tax
-41.56%-109M
-657.14%-117M
516.67%25M
106.73%7M
-300.00%-24M
21.43%-77M
90.91%21M
-112.77%-6M
23.53%-104M
160.00%12M
Other non cash items
13.73%58M
366.67%8M
-133.33%-2M
-133.33%-6M
93.33%58M
-79.10%51M
50.00%-3M
166.67%6M
1,900.00%18M
-88.46%30M
Change In working capital
-17.44%284M
50.51%447M
36.16%241M
-156.59%-73M
-27.80%-331M
-24.40%344M
51.53%297M
8.59%177M
-17.83%129M
-324.59%-259M
-Change in receivables
71.43%-16M
28.13%164M
-122.40%-28M
138.60%22M
30.95%-174M
-51.35%-56M
412.00%128M
150.00%125M
-3.64%-57M
-342.11%-252M
-Change in inventory
209.00%109M
1,766.67%100M
107.79%6M
417.86%89M
-881.82%-86M
-151.55%-100M
-113.64%-6M
-180.21%-77M
-135.90%-28M
145.83%11M
-Change in payables and accrued expense
-51.36%251M
16.93%221M
109.02%278M
-202.69%-191M
-812.50%-57M
66.99%516M
34.04%189M
786.67%133M
20.00%186M
500.00%8M
-Change in other current assets
25.00%35M
----
----
----
----
-47.17%28M
----
----
----
----
-Change in other current liabilities
-115.91%-95M
----
----
----
----
31.25%-44M
----
----
----
----
-Change in other working capital
----
----
-275.00%-15M
-75.00%7M
46.15%-14M
-45.45%-16M
0.00%-14M
-300.00%-4M
233.33%28M
-218.18%-26M
Cash from discontinued investing activities
Operating cash flow
2.22%4.2B
14.50%1.45B
8.05%1.26B
-10.71%884M
-11.89%600M
9.67%4.11B
11.71%1.27B
1.30%1.17B
37.12%990M
-7.35%681M
Investing cash flow
Cash flow from continuing investing activities
-53.00%-817M
-28.75%-103M
-2.67%-154M
-261.26%-401M
17.62%-159M
28.03%-534M
44.06%-80M
6.83%-150M
36.21%-111M
26.89%-193M
Capital expenditure reported
-0.53%-564M
3.80%-177M
-15.67%-155M
7.69%-108M
1.59%-124M
20.43%-561M
6.60%-184M
16.77%-134M
36.41%-117M
22.70%-126M
Net PPE purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net business purchase and sale
---293M
--0
--0
----
----
--0
--0
--0
----
----
Net investment purchase and sale
640.00%54M
-5.68%83M
115.15%5M
175.00%3M
39.34%-37M
-150.00%-10M
57.14%88M
-273.68%-33M
-121.05%-4M
37.76%-61M
Net other investing changes
-137.84%-14M
-156.25%-9M
-123.53%-4M
-130.00%-3M
133.33%2M
212.12%37M
900.00%16M
189.47%17M
211.11%10M
-100.00%-6M
Cash from discontinued investing activities
Investing cash flow
-53.00%-817M
-28.75%-103M
-2.67%-154M
-261.26%-401M
17.62%-159M
28.03%-534M
44.06%-80M
6.83%-150M
36.21%-111M
26.89%-193M
Financing cash flow
Cash flow from continuing financing activities
3.92%-3.26B
-6.41%-1.36B
-13.72%-1.03B
51.60%-409M
-26.87%-458M
-21.34%-3.39B
-28.93%-1.28B
-6.86%-904M
-45.69%-845M
3.73%-361M
Net issuance payments of debt
-11.76%-456M
-78.37%-437M
13.47%-347M
1,766.67%168M
-30.13%160M
-29.94%-408M
28.78%-245M
-169.13%-401M
-91.89%9M
236.76%229M
Net common stock issuance
30.42%-1.21B
10.77%-406M
2.37%-288M
51.67%-232M
44.20%-284M
-54.17%-1.74B
-85.71%-455M
11.14%-295M
-29.38%-480M
-182.78%-509M
Cash dividends paid
-1.90%-1.82B
-1.75%-523M
-2.94%-420M
-0.21%-474M
-3.05%-406M
-2.29%-1.79B
-1.58%-514M
-3.03%-408M
-3.50%-473M
-1.03%-394M
Proceeds from stock option exercised by employees
-84.17%101M
-33.33%18M
-88.46%18M
-78.99%25M
-88.10%40M
67.89%638M
-50.91%27M
136.36%156M
-13.14%119M
175.41%336M
Net other financing activities
245.05%132M
85.87%-13M
-79.55%9M
620.00%104M
239.13%32M
-605.56%-91M
-291.67%-92M
225.71%44M
---20M
-560.00%-23M
Cash from discontinued financing activities
Financing cash flow
3.92%-3.26B
-6.41%-1.36B
-13.72%-1.03B
51.60%-409M
-26.87%-458M
-21.34%-3.39B
-28.93%-1.28B
-6.86%-904M
-45.69%-845M
3.73%-361M
Net cash flow
Beginning cash position
13.46%1.1B
3.65%1.28B
9.46%1.22B
3.06%1.11B
13.46%1.1B
24.65%966M
29.76%1.23B
35.53%1.11B
24.45%1.08B
24.65%966M
Current changes in cash
-32.07%125M
87.78%-11M
-30.09%79M
117.65%74M
-113.39%-17M
-12.38%184M
-9,100.00%-90M
-22.07%113M
206.25%34M
32.29%127M
Effect of exchange rate changes
224.07%67M
141.67%20M
-236.36%-15M
1,066.67%29M
335.71%33M
-184.21%-54M
-442.86%-48M
184.62%11M
81.25%-3M
-250.00%-14M
End cash Position
17.52%1.29B
17.52%1.29B
3.65%1.28B
9.46%1.22B
3.06%1.11B
13.46%1.1B
13.46%1.1B
29.76%1.23B
35.53%1.11B
24.45%1.08B
Free cash flow
2.48%3.63B
17.60%1.28B
7.07%1.11B
-11.11%776M
-14.23%476M
16.64%3.55B
15.55%1.09B
4.24%1.03B
62.27%873M
-2.97%555M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.22%4.2B14.50%1.45B8.05%1.26B-10.71%884M-11.89%600M9.67%4.11B11.71%1.27B1.30%1.17B37.12%990M-7.35%681M
Net income from continuing operations -25.84%2.26B-100.64%-5M-1.03%767M0.91%773M-0.41%726M24.20%3.05B2.50%779M3.75%775M43.45%766M76.09%729M
Depreciation and amortization 4.13%630M16.89%173M5.33%158M-3.82%151M-1.33%148M6.70%605M-1.33%148M4.17%150M8.28%157M17.19%150M
Deferred tax -41.56%-109M-657.14%-117M516.67%25M106.73%7M-300.00%-24M21.43%-77M90.91%21M-112.77%-6M23.53%-104M160.00%12M
Other non cash items 13.73%58M366.67%8M-133.33%-2M-133.33%-6M93.33%58M-79.10%51M50.00%-3M166.67%6M1,900.00%18M-88.46%30M
Change In working capital -17.44%284M50.51%447M36.16%241M-156.59%-73M-27.80%-331M-24.40%344M51.53%297M8.59%177M-17.83%129M-324.59%-259M
-Change in receivables 71.43%-16M28.13%164M-122.40%-28M138.60%22M30.95%-174M-51.35%-56M412.00%128M150.00%125M-3.64%-57M-342.11%-252M
-Change in inventory 209.00%109M1,766.67%100M107.79%6M417.86%89M-881.82%-86M-151.55%-100M-113.64%-6M-180.21%-77M-135.90%-28M145.83%11M
-Change in payables and accrued expense -51.36%251M16.93%221M109.02%278M-202.69%-191M-812.50%-57M66.99%516M34.04%189M786.67%133M20.00%186M500.00%8M
-Change in other current assets 25.00%35M-----------------47.17%28M----------------
-Change in other current liabilities -115.91%-95M----------------31.25%-44M----------------
-Change in other working capital ---------275.00%-15M-75.00%7M46.15%-14M-45.45%-16M0.00%-14M-300.00%-4M233.33%28M-218.18%-26M
Cash from discontinued investing activities
Operating cash flow 2.22%4.2B14.50%1.45B8.05%1.26B-10.71%884M-11.89%600M9.67%4.11B11.71%1.27B1.30%1.17B37.12%990M-7.35%681M
Investing cash flow
Cash flow from continuing investing activities -53.00%-817M-28.75%-103M-2.67%-154M-261.26%-401M17.62%-159M28.03%-534M44.06%-80M6.83%-150M36.21%-111M26.89%-193M
Capital expenditure reported -0.53%-564M3.80%-177M-15.67%-155M7.69%-108M1.59%-124M20.43%-561M6.60%-184M16.77%-134M36.41%-117M22.70%-126M
Net PPE purchase and sale ----------------------0----------------
Net business purchase and sale ---293M--0--0----------0--0--0--------
Net investment purchase and sale 640.00%54M-5.68%83M115.15%5M175.00%3M39.34%-37M-150.00%-10M57.14%88M-273.68%-33M-121.05%-4M37.76%-61M
Net other investing changes -137.84%-14M-156.25%-9M-123.53%-4M-130.00%-3M133.33%2M212.12%37M900.00%16M189.47%17M211.11%10M-100.00%-6M
Cash from discontinued investing activities
Investing cash flow -53.00%-817M-28.75%-103M-2.67%-154M-261.26%-401M17.62%-159M28.03%-534M44.06%-80M6.83%-150M36.21%-111M26.89%-193M
Financing cash flow
Cash flow from continuing financing activities 3.92%-3.26B-6.41%-1.36B-13.72%-1.03B51.60%-409M-26.87%-458M-21.34%-3.39B-28.93%-1.28B-6.86%-904M-45.69%-845M3.73%-361M
Net issuance payments of debt -11.76%-456M-78.37%-437M13.47%-347M1,766.67%168M-30.13%160M-29.94%-408M28.78%-245M-169.13%-401M-91.89%9M236.76%229M
Net common stock issuance 30.42%-1.21B10.77%-406M2.37%-288M51.67%-232M44.20%-284M-54.17%-1.74B-85.71%-455M11.14%-295M-29.38%-480M-182.78%-509M
Cash dividends paid -1.90%-1.82B-1.75%-523M-2.94%-420M-0.21%-474M-3.05%-406M-2.29%-1.79B-1.58%-514M-3.03%-408M-3.50%-473M-1.03%-394M
Proceeds from stock option exercised by employees -84.17%101M-33.33%18M-88.46%18M-78.99%25M-88.10%40M67.89%638M-50.91%27M136.36%156M-13.14%119M175.41%336M
Net other financing activities 245.05%132M85.87%-13M-79.55%9M620.00%104M239.13%32M-605.56%-91M-291.67%-92M225.71%44M---20M-560.00%-23M
Cash from discontinued financing activities
Financing cash flow 3.92%-3.26B-6.41%-1.36B-13.72%-1.03B51.60%-409M-26.87%-458M-21.34%-3.39B-28.93%-1.28B-6.86%-904M-45.69%-845M3.73%-361M
Net cash flow
Beginning cash position 13.46%1.1B3.65%1.28B9.46%1.22B3.06%1.11B13.46%1.1B24.65%966M29.76%1.23B35.53%1.11B24.45%1.08B24.65%966M
Current changes in cash -32.07%125M87.78%-11M-30.09%79M117.65%74M-113.39%-17M-12.38%184M-9,100.00%-90M-22.07%113M206.25%34M32.29%127M
Effect of exchange rate changes 224.07%67M141.67%20M-236.36%-15M1,066.67%29M335.71%33M-184.21%-54M-442.86%-48M184.62%11M81.25%-3M-250.00%-14M
End cash Position 17.52%1.29B17.52%1.29B3.65%1.28B9.46%1.22B3.06%1.11B13.46%1.1B13.46%1.1B29.76%1.23B35.53%1.11B24.45%1.08B
Free cash flow 2.48%3.63B17.60%1.28B7.07%1.11B-11.11%776M-14.23%476M16.64%3.55B15.55%1.09B4.24%1.03B62.27%873M-2.97%555M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More